alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 802 Introduced in House (IH)]

<DOC>

118th CONGRESS
  1st Session
                                H. R. 802

 To amend the CARES Act to remove a requirement on lessors to provide 
               notice to vacate, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            February 2, 2023

Mr. Loudermilk (for himself, Mr. Rutherford, Mr. Barr, Mr. Timmons, Mr. 
Duncan, Mr. Flood, and Mr. Norman) introduced the following bill; which 
          was referred to the Committee on Financial Services

_______________________________________________________________________

                                 A BILL

 
 To amend the CARES Act to remove a requirement on lessors to provide 
               notice to vacate, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Respect State Housing Laws Act''.

SEC. 2. NOTICE.

    Section 4024 of the CARES Act (15 U.S.C. 9058) is amended by 
striking subsection (c).
                                 <all>
```
AFS

- 13

- 440

- E August 26, 2013

Exemption No. 10377A Regu latory Docket No. FAA

- 2011

- 0892

Mr. Jeffrey J. Jenkins Chief Inspector, Part 135
PHI, Inc.

P.O. Box 90808 Lafayette, LA 70509

Dear M r. Jenkins:

This letter is to inform you that we have granted your petition to extend and amend Exemption No. 10377

. It explains the basis for our decision, describes its effect, and lists the

conditions and limitations

.

The Basis for Our Decision

By le tter dated June 25, 2013, you petitioned the Federal Aviation Administration (FAA) on behalf of PHI, Inc. (PHI), for an extension to Exemption No. 10377. That exemption from §§ 91.411(b) and 91.413(c) of Title 14, Code of Federal Regulations (14 CFR ) allo w s PHI to perform air traffic control (ATC) transponder tests and inspections and altimeter system an d altimeter reporting equipment tests and inspections for its part 1 19 aircraft maintained under a continuous airworthiness maintenance program (CAMP) . Th e exemption also allow s PHI to perform similar tests and inspections on its part 135 aircraft maintained under an approved aircraft inspection program (AAIP)

.

In your petition, you indicate that there has been no change in the conditions and reasons

relat ive to public interest and safety that were the basis for granting the original exemption. PHI has requested, however, that it be permitted to accomplish the tests and inspections allowed by this exemption when operating outside the United States. We hav e reviewed the corresponding International Civil Aviation Organization (ICAO) Standards and Recommended Practices and have identified no differences with the regulation from which we grant this exemption. However, a foreign country still may not allow you to operate in that country under this exemption if it so chooses.2

Our Decision

The FAA has determined that the justification for the extension and amendment of Exemption No. 10377

, remains valid with respect to this exemption and is in the public

interes t. Therefore, under the authority provided by 49 U.S.C. 40113 and 44701

, which the FAA Administrator has delegated to me, I grant your petition, subject to the following

conditions and limitations.

Conditions and Limitations

1. All ATC transponder tests an d inspections and all altimeter reporting equipment tests and inspections must be conducted under PHI’s part 119 CAMP.

2. All tests and inspections must be recorded in the aircraft’s maintenance log by the person performing each inspection and test. This entry must identify the person, the date, and this exemption number.

3. An appropriate record of these tests and inspections also must be kept in PHI’s maintenance recording system for part 119 and part 135.

4. PHI may operate outside the U.S. under this exemp tion, unless otherwise prohibited by a foreign country.

The Effect of Our Decision

Our decision extends the termination date of Exemption No. 10377, to October 31, 2015, unless sooner superseded or rescinded.

Sincerely,

/s/

Michael J. Zenkovich Deputy Director, Flight Standards

Service
Editorial Note on Part 882
Editorial Note: Nomenclature changes to part 882 appear at 73 FR 35341, June 23, 2008.

§ 882.5850 Implanted spinal cord stimulator for bladder evacuation. ( a ) *Identification.* An implanted spinal cord stimulator for bladder evacuation is an electrical stimulator used to empty the bladder of a paraplegic patient who has a complete transection of the spinal cord and who is unable to empty his or her bladder by reflex means or by the intermittent use of catheters. The stimulator consists of an implanted receiver with electrodes that are placed on the conus medullaris portion of the patient's spinal cord and an external transmitter for transmitting the stimulating pulses across the patient's skin to the implanted receiver.
( b ) *Classification.* Class III (premarket approval).
( c ) *Date PMA or notice of completion of a PDP is required.* A PMA or a notice of completion of a PDP is required to be filed with the Food and Drug Administration on or before December 26, 1996 for any implanted spinal cord stimulator for bladder evacuation that was in commercial distribution before May 28, 1976, or that has, on or before December 26, 1996 been found to be substantially equivalent to an implanted spinal cord stimulator for bladder evacuation that was in commercial distribution before May 28, 1976. Any other implanted spinal cord stimulator for bladder evacuation shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution.
[44 FR 51730, Sept. 4, 1979, as amended at 52 FR 17740, May 11, 1987; 61 FR 50708, Sept. 27, 1996]
I 

118TH CONGRESS 

2D SESSION H. R. 8095 

To amend the Internal Revenue Code of 1986 to extend the energy credit 

with respect to electrochromic glass. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 19, 2024 

Mr. KELLY of Mississippi (for himself, Mr. HORSFORD, and Mr. LAHOOD) introduced the following bill; which was referred to the Committee on Ways 

and Means 

A BILL 

To amend the Internal Revenue Code of 1986 to extend 

the energy credit with respect to electrochromic glass. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. EXTENSION OF ENERGY CREDIT FOR 

4 ELECTROCHROMIC GLASS. 

5 (a) IN GENERAL.—Section 48(a)(3)(A) of the Inter6 nal Revenue Code of 1986 is amended— 

7 (1) in clause (ii), by striking ‘‘, or 

8 electrochromic glass which uses electricity to change 

9 its light transmittance properties in order to heat or 

10 cool a structure’’, 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 8095 IH

1 (2) in clause (x), by striking ‘‘or’’. 

2 (3) in clause (xi), by inserting ‘‘or’’ after the 

3 comma at the end, and 

4 (4) by adding at the end the following new 

5 clause: 

6 ‘‘(xii) electrochromic glass which uses 

7 electricity to change its light transmittance 

8 properties in order to heat or cool a struc9 ture, but only with respect to property the 

10 construction of which begins before Janu11 ary 1, 2033,’’. 

12 (b) CONFORMING AMENDMENT.—Section 

13 48(a)(2)(A)(i)(III) of such Code is amended by striking 

14 ‘‘paragraph (3)(A)(ii)’’ and inserting ‘‘clause (ii) or (xii) 

15 of paragraph (3)’’. 

16 (c) EFFECTIVE DATE.—The amendments made by 

17 this section shall apply to property placed in service after 

18 the date of the enactment of this Act. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
California Environmental Protection Agency AIR RESOURCES BOARD Executive Order5-09-014 WHEREAS, AttachmentA hereto sets forth the currently effective version ofthe California Regulation for Reducing Emissions from Consumer Products (title 17, California Code of Regulations, Subchapter 8.5, Article 2, sections 94508-94517 (Consumer Products Regulation), as adopted by the California Air Resources Board; WHEREAS, Attachment B hereto identifies the regulatory action in which the Air Resources Board amended the Consumer Products Regulation setforth in AttachmentA; WHEREAS, the Consumer Products Regulation setforth in Attachment A incorporates all ofthe amendments made by the regulatory action identified in Attachment B; WHEREAS, the Air Resources Board is authorized to adopt, amend, and enforce the referenced regulation by California Health and Safety Code sections 39600,39601, 39607, and 41712; WHEREAS, the referenced regulation has been duly adopted and amended by the Air Resources Board through regulatory actionstaken in accordancewith the California Administrative ProcedureAct as set forth in Chapter 3.5 (commencing with section 11340), Part 1, Division 3, Title 2, ofthe Government Code, and in accordance with other applicable laws; WHEREAS, the regulatory action incorporated in and reflected by the referenced regulation was approved by the California Office ofAdministrative Law, and thereafter became effective under State law; WHEREAS, the Air Resources Board is authorized by California Health and Safety Code sections 39601 and 39602 to adopt and amend its regulations as revisions to the State ofCalifornia Implementation Plan forAchieVingandMaintaining the National AmbientAirQualityStandards (SIP); WHEREAS, the adoption ofthe regulation setforth in AttachmentA as a revision tothe SIP is necessaryto meetthe requirements ofthe federal Clean AirAct; and WHEREAS, by the Resolution 08-30 and Executive Order R-08-016, the Air Resources Board adopted the regulatory action identified in Attachment B, and directed the Executive Officerto submitthis material to the United States Environmental Protection Agency for inclusion in the SIP, and to include in the SIP revisions any additional documentation identified as necessary for approvability underthe federal Clean AirAct 

### 1and United States Environmental Protection Agency Regulations; THEREFORE, IT IS ORDERED, pursuantto sections 39515 and 39516 ofthe California Health and Safety Code, thatthe regulation setforth in Attachments A and B hereto is hereby adopted as a revision to the SIP and forwarded to the U.S. Environmental Protection Agency. I certify, pursuantto 40 Code of Federal Regulations, 51.102(f), thatthe regulation set forth in Attachments A and B was adopted oramended after notice and public hearings as required by 40 Code of Federal Regulations 51.102(d). Execdted this 

# //fit day of 

### >.U£l/fJ"pj)/ ,2010, at Sacramento, California. 

# (7

Enclosure

2
Editorial Note on Part 886
Editorial Note: Nomenclature changes to part 886 appear at 73 FR 35341, June 23, 2008.

§ 886.4392 Nd:YAG laser for posterior capsulotomy and peripheral iridotomy. ( a ) *Identification.* The Nd:YAG laser for posterior capsulotomy and peripheral iridotomy consists of a mode-locked or Q-switched solid state Nd:YAG laser intended for disruption of the posterior capsule or the iris via optical breakdown. The Nd:YAG laser generates short pulse, low energy, high power, coherent optical radiation. When the laser output is combined with focusing optics, the high irradiance at the target causes tissue disruption via optical breakdown. A visible aiming system is utilized to target the invisible Nd:YAG laser radiation on or in close proximity to the target tissue.
( b ) *Classification.* Class II (special controls). Design Parameters: Device must emit a laser beam with the following parameters: wavelength = 1064 nanometers; spot size = 50 to 100 micros; pulse width = 3 to 30 nanoseconds; output energy per pulse = 0.5 to 15 millijoules (mJ); repetition rate = 1 to 10 pulses; and total energy = 20 to 120 mJ.
[65 FR 6894, Feb. 11, 2000]
Neuroinvasiv e Encephalitis / Meningitis Feve r Unspecified Clinical 1999 1 59 3 62 7 2000 3 19 2 21 2 2001 10 64 2 33 9 2002 40 2946 1160 50 4516 284 2003 46 2866 6830 166 9862 264 2004 41 1142 1269 128 2539 100 2005 44 1294 1607 99 3000 119 2006 44 1459 2616 194 4269 177 2007 43 1130 2215 59 3404 98 2008 46 687 624 45 1356 44

According to CDC, the counts of neuroinvasive WNV are more accurate than fever or other clinical symptoms for the entire range of this time period. 

## Cases of West Nile Virus in the U.S. Data from CDC Division of Vector-Borne Infectious Diseases Number of States Year Total Deaths Non-neuroinvasive



### Cases of Neuroinvasive West Nile Virus in the U.S. 1999 - 2008 0 500 1,000 1,500 2,000 2,500 3,000 3,500 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008# of cases 

### Deaths from West Nile Virus in the U.S. 1999-2008

0 50 100 150 200 250 300 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008# of deaths
1

Troutman, Jake (FAA)

From: Hamilton, Paul CTR (FAA)

Sent: Friday, March 10, 2017 7:42 AM

To: pjones@martinuav.com

Cc: Troutman, Jake (FAA); Cappelle, Michele (FAA)

Subject: Request for Information

Mr. Jones:

Since our regulatory group has temporarily suspended posting requests for information to the public docket, I’ve been

authorized to send the equivalent request via e‐mail instead.  The information listed below as well as your response will

be posted to the docket at a later date.  If you have any questions, please call or e‐mail at your convenience.

• A detailed description of the aircraft design and configuration for the V‐Bat, focusing on the UAS features

and flight characteristics to include, but not limited to:  

o Aircraft weights and center of gravity range

o Detailed 3 view drawings with scale of the aircraft and any launch and recovery equipment if

applicable  

o Operational history with supporting statistics.

o Results of analysis and flight testing of UAS

o Lessons learned from repairs and alterations performed during operations to include design

changes and fixes due to operational failure(s)

o Details of any injuries or property damage resulting from flight/ground operations

o Safety analysis of any failure modes such as lost link, fly‐away, loss of control, etc.

• Copies of manuals, photographs, videos/telemetry may be provided as support

• Any other information to support an analysis of operational safety with unmanned aircraft in excess of 55

pounds.

Thanking you in advance,

Paul  

Paul Hamilton / SAIC 

Senior Policy Analyst – AVS Safety Technical Services Support contract

Flight Technologies and Procedures Division - Management Operations Branch (DC) 

Email: paul.ctr.hamilton@faa.gov

Direct: 202-267-4773
I 

118TH CONGRESS 

2D SESSION H. R. 8110 

To amend title XIX of the Social Security Act to make permanent the 

State option to extend protection against spousal impoverishment for 

recipients of home and community-based services under Medicaid. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 23, 2024 

Mrs. DINGELL (for herself and Mr. JAMES) introduced the following bill; 

which was referred to the Committee on Energy and Commerce 

A BILL 

To amend title XIX of the Social Security Act to make 

permanent the State option to extend protection against 

spousal impoverishment for recipients of home and community-based services under Medicaid. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Protecting Married 

5 Seniors from Impoverishment Act of 2024’’. 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•HR 8110 IH

1 SEC. 2. MAKING PERMANENT THE STATE OPTION TO EX2 TEND PROTECTION AGAINST SPOUSAL IM3 POVERISHMENT FOR RECIPIENTS OF HOME 

4 AND COMMUNITY-BASED SERVICES UNDER 

5 MEDICAID. 

6 (a) IN GENERAL.—Section 1924(h)(1)(A) of the So7 cial Security Act (42 U.S.C. 1396r–5(h)(1)(A)) is amend8 ed by striking ‘‘(at the option of the State) is described 

9 in section 1902(a)(10)(A)(ii)(VI)’’ and inserting the fol10 lowing: ‘‘is eligible for medical assistance for home and 

11 community-based services provided under subsection (c), 

12 (d), or (i) of section 1915, under a waiver approved under 

13 section 1115, or who is eligible for such medical assistance 

14 by reason of being determined eligible under section 

15 1902(a)(10)(C) or by reason of section 1902(f) or other16 wise on the basis of a reduction of income based on costs 

17 incurred for medical or other remedial care, or who is eligi18 ble for medical assistance for home and community-based 

19 attendant services and supports under section 1915(k)’’. 

20 (b) CONFORMING AMENDMENT.—Section 2404 of the 

21 Patient Protection and Affordable Care Act (42 U.S.C. 

22 1396r–5 note) is amended by striking ‘‘September 30, 

23 2027’’ and inserting ‘‘the date of enactment of the Pro24 tecting Married Seniors from Impoverishment Act of 

25 2024’’. 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS
EXHIBIT
32
 
 CERTIFICATION
PURSUANT TO
 18 U.S.C.
SECTION 1350,
 AS
ADOPTED PURSUANT TO
 SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
 
 In
connection with the Quarterly Report of Fonix Corporation on Form 10-Q for the
period ending March 31, 2009, as filed with the Securities and Exchange
Commission on the date hereof (the "Report"), I, Roger D. Dudley, Chief
Executive Officer and Chief Financial Officer of the Company, certify, pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:
 
 (1)           The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
 
 (2)           The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
 
 
 
 /s/ Roger D. DudleyRoger
      D. DudleyPresident,
      Chief Executive Officer, andChief
      Financial Officer(Principal
      Executive Officer, Principal Accounting Officer)
 Dated:
June 10, 2009
Exhibit 12.2

 

CERTIFICATION

 

I, Jean-Fabien Monin, certify that:

 

1.       I have reviewedthis annual report on Form 20-F of AC Immune SA;

 

2.       Based on my knowledge,this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statementsmade, in light of the circumstances under which such statements were made, not misleading with respect to the period covered bythis report;

 

3.       Based on my knowledge,the financial statements, and other financial information included in this report, fairly present in all material respects thefinancial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;

 

4.       The company’sother certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as definedin Exchange Act Rules 13a-15(e) and 15d-15(e)) for the company and have:

 

(a)       Designed such disclosurecontrols and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure thatmaterial information relating to the company, including its consolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this report is being prepared;

 

(b)       Evaluated the effectivenessof the company’s disclosure controls and procedures and presented in this report our conclusions about the effectivenessof the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(c)       Disclosed in thisreport any change in the company’s internal control over financial reporting that occurred during the period covered by theannual report that has materially affected, or is reasonably likely to materially affect, the company’s internal controlover financial reporting; and

 

5.       The company’sother certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting,to the company’s auditors and the audit committee of the company’s board of directors (or persons performing the equivalentfunctions):

 

(a)       All significantdeficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonablylikely to adversely affect the company’s ability to record, process, summarize and report financial information; and

 

(b)       Any fraud, whetheror not material, that involves management or other employees who have a significant role in the company’s internal controlover financial reporting.

 

Date:	March 17, 2017
# C_2014159EN.01003202.xml

| 26.5.2014 | EN | Official Journal of the European Union | C 159/32 |
| --- | --- | --- | --- |

26.5.2014

EN

Official Journal of the European Union

C 159/32

---

Action brought on 5 March 2014 — Medilab v Commission and ECB

(Case T-152/14)

2014/C 159/44

Language of the case: English

Parties

Parties

Applicant: Medilab Ltd (Nicosia, Cyprus) (represented by: C. Paschalides, Solicitor, and A. Paschalides, lawyer)

Applicant:

Defendants: European Central Bank and European Commission

Defendants:

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | Order the defendants to compensate the applicant under Article 268 of the TFEU. |
| --- | --- |

—

Order the defendants to compensate the applicant under Article 268 of the TFEU.

Pleas in law and main arguments

Pleas in law and main arguments

The applicant contends that the defendants caused him to be deprived of the money in his account because they induced the premature imposition of a bail-in tool on his deposit with his bank as part of the conditionality attached to financial assistance provided to Cyprus on 26 April 2013 pursuant to Article 13 of the European Stability Mechanism Treaty of 2012 as follows: a) the defendants ‘manifestly and gravely disregarded the limits’ on their power as EU institutions under Article 136(3) of the TFEU; b) unlawfully surrendered effective control of their functions as EU institutions; c) induced the premature passing of a bail-in tool on deposits with Bank of Cyprus and Cyprus Popular Bank which had not been passed into the EU law; d) induced restrictions on the movement of money preventing deposit holders from withdrawing and/or transferring their funds to safer institutions; and e) did so in breach of the principles of legal certainty, equality and human rights.

---
<Page>


                                                                          [LOGO]

                        CONSENT OF INDEPENDENT ACCOUNTANTS

We hereby consent to the use in this Post-Effective Amendment No. 25 to the
registration statement on Form N-4 (No. 033-19421) (the "Registration
Statement") of our report dated February 13, 2003, relating to the financial
statements of Fortis Benefits Insurance Company, which appears in such
Registration Statement.  We also consent to the reference to us under the
heading "Independent Accountants" in such Registration Statement.

PRICEWATERHOUSECOOPERS LLP
Minneapolis, Minnesota
April 7, 2003
Editorial Note on Part 890
Editorial Note: Nomenclature changes to part 890 appear at 73 FR 35341, June 23, 2008.

§ 890.3850 Mechanical wheelchair. ( a ) *Identification.* A mechanical wheelchair is a manually operated device with wheels that is intended for medical purposes to provide mobility to persons restricted to a sitting position.
( b ) *Classification.* Class I (general controls).